Dosentrx

Company Overview

Snapshot

Founded in October 2011 by Alan Paz, Dosentrx operates with 11–50 employees. The company has secured funding across three rounds from Engage Venture Partners and East Post Road Ventures. In January 2025, Dosentrx received funding from Engage Venture Partners.

Business overview

Dosentrx develops ReX, an all-in-one oral medication dispensing solution integrated with a customized digital therapy program and remote care management system. This centralized system helps healthcare organizations engage patients during treatment and supports the entire care team. The company aims to enhance patient adherence, provide real-time insights, and facilitate interventions, thereby improving communication and outcomes for patients and care providers in the Health Tech & Life Sciences sector.

Strategic signal

In August 2020, Dosentrx partnered with Choice Specialty Pharmacy to implement its technology for managing and monitoring home-based medication therapy across the United States. This collaboration signals a strategic expansion of Dosentrx's reach within the US market and validates the practical application of its medication management platform in real-world patient care settings, indicating potential for broader adoption and impact.

Company Intelligence Q&A

When was Dosentrx founded?

Dosentrx was founded in October 2011 by Alan Paz.

What is the primary product offered by Dosentrx?

Dosentrx offers ReX, a comprehensive platform that combines an oral medication dispensing solution with a digital therapy program and remote care management system.

Has Dosentrx received any grants?

In February 2020, Dosentrx secured a grant from the "Digital Israel" Project, with support from the Israel Innovation Authority.

What significant partnership did Dosentrx announce in August 2020?

In August 2020, Dosentrx announced a partnership with Choice Specialty Pharmacy to deploy its medication management and monitoring technology for home-based therapy across the United States.